SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001420720-23-000030
Filing Date
2023-06-20
Accepted
2023-06-20 08:59:56
Documents
13
Period of Report
2023-06-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20230619x8k.htm   iXBRL 8-K 26210
  Complete submission text file 0001420720-23-000030.txt   146344

Data Files

Seq Description Document Type Size
2 EX-101.SCH ibio-20230619.xsd EX-101.SCH 3943
3 EX-101.DEF ibio-20230619_def.xml EX-101.DEF 3263
4 EX-101.LAB ibio-20230619_lab.xml EX-101.LAB 13480
5 EX-101.PRE ibio-20230619_pre.xml EX-101.PRE 10083
7 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20230619x8k_htm.xml XML 4621
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 231023620
SIC: 2834 Pharmaceutical Preparations